Chroniques génomiques - Les débuts de CRISPR en thérapie génique
Résumé
Two clinical trials using CRISPR technology to engineer the T cells of cancer patients by inactivating the gene for immune checkpoint molecule PD-1 are (almost) underway, one in the USA and the other in China. The less sophisticated Chinese trial seems slated to begin first, in part because of very speedy approval ; it may however trigger autoimmune reactions that could be very serious.
Pour citer ce document
Jordan, Bertrand ; Chroniques génomiques - Les débuts de CRISPR en thérapie génique, Med Sci (Paris), , Vol. 32, N° 11 ; p. 1035-1037 ; DOI : 10.1051/medsci/20163211024